PRODUCTS

Catalog Number:RP0004
Recombinant Human FGF-10
Copy Product Information

Size:

50 μg

500 μg

Price:

$504.00

$2016.00

Delivery: Order now, ship in 3 days

Product Details
Product Name Recombinant Human FGF-10 Accesstion Number O15520
Alternative Names Fibroblast growth factor 10;FGF-10;Keratinocyte growth factor 2;FGF10;KGF-2;KGF2
Description Recombinant Human Fibroblast Growth Factor 10 is produced by our E.coli expression system and the target gene encoding Gln38-Ser208 is expressed.
Calculated Molecular Weight Mol Mass:19.5 KDa; APMol Mass:19-22 KDa, reducing conditions Formulation Lyophilized from a 0.2 μm filtered solution of 10mM Tris, 5% Sucrose, 4% Mannitol, 0.02% Tween80, pH8.0.
Endotoxin < 0.01 EU/µg as determined by LAL test. Purity Greater than 95% as determined by reducing SDS-PAGE.
Biological Activity Mouse Gastric organoids were cultured with EGF, Wnt3a, Noggin , R-spondin 1 and FGF-10. The organoids showed good morphology.|Mouse bile duct organoids were cultured with EGF ( , R-spondin 1 ( ,FGF-10 and HGF . The organoids showed good morphology.|Human breast cancer organoids were cultured with Wnt3a , Noggin , R-spondin 3 , KGF, FGF-10 , EGF and NRG1-beta 1 . The organoids showed good morphology.
Reconstitution Always centrifuge tubes before opening.Do not mix by vortex or pipetting. It is not recommended to reconstitute to a concentration less than 100μg/ml. Dissolve the lyophilized protein in distilled water. Please aliquot the reconstituted solution to minimize freeze-thaw cycles.
Storage Lyophilized protein should be stored at ≤ -20°C, stable for one year after receipt. Reconstituted protein solution can be stored at 2-8°C for 2-7 days. Aliquots of reconstituted samples are stable at ≤ -20°C for 3 months.
Shipping The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature listed below.
Background Fibroblast growth factor 10 (FGF-10, KGF-2), is a member of the fibroblast growth factor (FGF) family that includes FGF-3, -7, and -22. KGF-2 is secreted by mesenchymal cells and associates with extracellular FGF-BP. It preferentially binds and activates epithelial cell FGFR2 and interacts more weakly with FGFR1. It plays an important role in the regulation of embryonic development, cell proliferation and cell differentiation. It exhibits mitogenic activity for keratinizing epidermal cells, but essentially no activity for fibroblasts, which is similar to the biological activity of FGF7. FGF10 is required for normal branching morphogenesis. Defects in FGF10 are the cause of autosomal dominant aplasia of lacrimal and salivary glands (ALSG). ALSG has variable expressivity, and affected individuals may have aplasia or hypoplasia of the lacrimal, parotid, submandibular and sublingual glands and absence of the lacrimal puncta. The disorder is characterized by irritable eyes, recurrent eye infections, epiphora (constant tearing) and xerostomia (dryness of the mouth), which increases the risk of dental erosion, dental caries, periodontal disease and oral infections.
  • Greater than 95% as determined by reducing SDS-PAGE.
  • Measured by its ability to induce FGFRIIIb receptor activity in HEK293T human embryonic kidney cells.The ED50 for this effect is 3.82ng/ml (Regularly tested).